MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$190,700K
Net Income
-$43,200K
Net Profit Margin
-22.65%
EPS
-$0.46
Unit: Thousand (K) dollars
Revenue Breakdown
Cancer Care Continuum
Prenatal Health
Mental Health
Revenue Breakdown
US
Non Us
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
190,700
200,400
209,800
205,700
Cost of revenue
63,700
62,800
63,000
61,900
Gross profit
127,000
137,600
146,800
143,800
Research and development expense
25,000
27,100
25,500
28,200
Sales and marketing expense
83,100
73,600
68,700
71,000
General and administrative expense
57,800
62,200
55,600
67,900
Legal settlements
-
-
0*
-
Goodwill and long-lived asset impairment charges
0
5,400
2,700*
0
Total operating expenses
165,900
168,300
152,500
167,100
Operating loss
-38,900
-30,700
-5,700
-23,300
Interest income
400
700
800
500
Interest expense
4,100
4,100
4,400
3,800
Other
0
0
400
400
Total other expense, net
-3,700
-3,400
-3,200
-2,900
Loss before income tax
-42,600
-34,100
-8,900
-26,200
Income tax expense (benefit)
600
0
-1,000
1,200
Net loss
-43,200
-34,100
-7,900
-27,400
Basic EPS
-0.46
-0.36
-0.085
-0.29
Diluted EPS
-0.46
-0.36
-0.085
-0.29
Basic Average Shares
94,800,000
93,700,000
93,400,000
93,100,000
Diluted Average Shares
94,800,000
93,700,000
93,400,000
93,100,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
US
$100,900K
(-49.09%↓ Y/Y)
Non Us
$13,200K
(-11.41%↓ Y/Y)
Revenue From Contract
With Customer...
$39,800K
Revenue From Contract
With Customer...
$36,800K
Net loss
-$43,200K
(86.93%↑ Y/Y)
Cancer Care Continuum
$114,100K
Prenatal Health
$39,800K
Mental Health
$36,800K
Loss before income
tax
-$42,600K
(87.11%↑ Y/Y)
Income tax expense
(benefit)
$600K
(700.00%↑ Y/Y)
Revenue
$190,700K
(-10.51%↓ Y/Y)
Operating loss
-$38,900K
(88.18%↑ Y/Y)
Total other expense,
net
-$3,700K
(-164.29%↓ Y/Y)
Gross profit
$127,000K
(-16.34%↓ Y/Y)
Interest income
$400K
(100.00%↑ Y/Y)
Cost of revenue
$63,700K
(3.92%↑ Y/Y)
Total operating
expenses
$165,900K
(-65.51%↓ Y/Y)
Interest expense
$4,100K
(173.33%↑ Y/Y)
Sales and marketing
expense
$83,100K
(15.58%↑ Y/Y)
General and
administrative expense
$57,800K
(-13.47%↓ Y/Y)
Research and development
expense
$25,000K
(-2.34%↓ Y/Y)
Buy us a coffee
MYRIAD GENETICS INC (MYGN)
MYRIAD GENETICS INC (MYGN)